Intricate Forte, Inc.
USPTO PatentsView assignee record - 6 granted patents across 1 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A43B (Characteristic Features OF FOOTWEAR; Parts OF Footwear).
The verdict
According to USPTO PatentsView, Intricate ranks #41,010 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 1 technology areas.
- #41,010
- of 49,997 US assignees by volume
- 3rd percentile
- by Innovation Score (16.1/100)
- 4.2
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R41010 · US Corporation #41,010 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #41,010/49,997
- PHOTO-FINISH International-drug-d…
- CPC-NARROW A43B · 1 areas
- INNOV-LOW 16.1/100
- CLAIMS-SPARSE 4.2 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2022 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: International-drug-development-biotech (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Intricate’s 16.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Intricate
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Intricate Forte · this assignee 16
Intricate Forte · this assignee
16 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Intricate's Innovation Score is 16.1/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Intricate?
Each dot is one of Intricate’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intricate’s own 4.2 claims/patent is at or below the 13.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Intricate's grants concentrate
Intricate Forte, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 33.3% of grants classified under A43B (Characteristic Features OF FOOTWEAR; Parts OF Footwear). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2021. By volume, Intricate sits between International-drug-development-biotech and Invoxia.
Intricate's three-year grant acceleration
Intricate Forte, Inc. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Intricate's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- International-dru…
International-drug-development-biotech
6 patents
- Interson
Interson Corporation
6 patents
- Intocare Medical…
Intocare Medical Technology (SUZHOU) Co., Ltd
6 patents
- Intpro
Intpro, LLC
6 patents
- Inus
Inus Co., Ltd.
6 patents
- Inversa Systems
Inversa Systems Ltd.
6 patents
- Invivogen
Invivogen
6 patents
- Invoxia
Invoxia
6 patents
- Intricate Forte ◀
Intricate Forte, Inc.
6 patents
What this shows Intricate holds 6 patents at rank #40,911, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Intricate
By rank, the assignees closest to #40,911 in granted patent volume.
- International-drug-development-biotech #40,907 · 6 patents
- Interson Corporation #40,908 · 6 patents
- Intocare Medical Technology (SUZHOU) Co., Ltd #40,909 · 6 patents
- Intpro, LLC #40,910 · 6 patents
- Inus Co., Ltd. #40,912 · 6 patents
- Inversa Systems Ltd. #40,913 · 6 patents
- Invivogen #40,914 · 6 patents
- Invoxia #40,915 · 6 patents
Leaders in A43B (Characteristic Features OF Footwear)
Other assignees with the most granted patents in Intricate's primary technology class.
Intricate's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
16 3rd percentile higher than 3% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 50.0% |
| 2021 | 1 | 16.7% |
| 2022 | 2 | 33.3% |
Which technologies does Intricate Forte, Inc. patent most?
Top 1 of 1 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Intricate Forte, Inc.'s patent record in context - here's where to go next.
- Intricate Forte, Inc.'s lead technology class is A43B (Characteristic Features OF FOOTWEAR; Parts OF Footwear), 33.3% of its portfolio - see every assignee active in that class. Explore A43B
- Ranked #41,010 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Intricate Forte, Inc. against International-drug-development-biotech, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 16.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.